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ABSTRACT
A diagnostic microarray was used to characterise a collection of methicillin-resistant Staphylococcus
aureus (MRSA) isolates from hospitals in the German region of Eastern Saxony. The most abundant
epidemic MRSA (EMRSA) strains were ST5-MRSA II (Rhine–Hesse EMRSA, EMRSA-3), CC5 ⁄ ST228-
MRSA I (South German EMRSA), ST22-MRSA IV (Barnim EMRSA, EMRSA-15) and ST45-MRSA IV
(Berlin EMRSA). Other strains were found only as sporadic isolates or in minor outbreaks. These strains
included ST1-MRSA IV, ST8-MRSA IV (Hannover EMRSA and others), clonal group 5 strains carrying
SCCmec type IV elements (Paediatric clone), ST45-MRSA V, CC8 ⁄ ST239-MRSA III and ST398-MRSA
V. Panton–Valentine leukocidin-positive MRSA isolates were still very rare. The predominant strain was
ST80-MRSA IV, although increasing numbers of different strains have recently been detected (ST8-
MRSA IV, ST30-MRSA IV and ST59-MRSA V). For more common MRSA strains, it was possible to
detect variants that differed mainly in the carriage of additional resistance determinants and certain
virulence-associated genes. Detection of such variants can sometimes allow epidemic strains to be
resolved beyond spa types to a hospital-specific level, which is of significant value for epidemiological
purposes.
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INTRODUCTION
Methicillin-resistant Staphylococcus aureus (MRSA)
evolved in the late 1960s and has subsequently
spread worldwide. MRSA strains carrying
SCCmec element types I–III [1] were, for many
years, epidemiologically linked to hospital-ac-
quired infections. This link was explained by the
adverse effects of high oxacillin resistance on
replication [2] and by increased glucose con-
sumption resulting in a decreased growth rate
and cell yield [3]. Thus, MRSA had a selective
advantage only in a hospital environment with
high exposure to antibiotics. Outside of hospitals,
where this selective pressure was not maintained,
MRSA could not compete with fast-growing wild-
type strains. However, within the last decade, the
epidemiological picture has changed profoundly.
The novel SCCmec types IV and V [4,5] have
appeared, which apparently do not have negative
effects on replication [3]. Strains carrying these
novel elements spread rapidly in hospitals, and
have also appeared in communities outside hos-
pitals, even in remote settings [6]. These strains
have been designated ‘community-associated’
MRSA (caMRSA). Some caMRSA strains produce
Panton–Valentine leukocidin (PVL) [7], which is
a virulence factor that is associated with chronic
or complicated skin and soft-tissue infections,
as well as with rapidly fatal pneumonia
[8]. Currently, the simultaneous presence of
‘hospital-acquired’ PVL-negative SCCmecI–IV,
‘community-acquired’ PVL-negative SCCmecIV
or SCCmecV, and ‘community-acquired’ PVL-
positive SCCmecIV or SCCmecV MRSA strains
can be observed. The latter strains have also been
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found to cause outbreaks in hospitals [9], which is
of particular concern because of their enhanced
virulence.
The use of a DNA microarray to genotype
S. aureus isolates has been reported previously
[10–13]. The array was shown to detect a large
number of genes related to antibiotic resistance
and exotoxin production, and was able to detect
the type of agr operon. This array has been
extended with new probes designed to characte-
rise additional virulence and pathogenicity-
related genes. These additional targets include
the allelic variants of ccrA ⁄ ccrB, the more distantly
related ccrAA ⁄ ccrC, hlb-converting phages, which
integrate specifically into the hlb gene and which
carry enterotoxin genes as well as the innate
immune evasion gene cluster (IEC) [14], and
known variants of the cap operon.
S. aureus also possesses several proteins that
are excreted and then attached covalently to the
cell surface. These proteins have been referred to
as microbial surface components recognising
adhesive matrix molecules (MSCRAMMs) [15].
The number of these genes and their length are
variable. The differences in size can be attributed
to a variable number of repeated sequence
elements; however, the array was designed to
detect more conserved regions, specific for clonal
complexes, rather than these repeating units.
The objective of the present study was to
apply the new diagnostic microarray to the
routine identification and characterisation of
MRSA isolates, including the determination of
SCCmec types, and to obtain an insight into the
presence and genetic characteristics of epidemic
MRSA (EMRSA) strains in Eastern Saxony.
MATERIALS AND METHODS
Bacterial strains and isolates
The study was performed with isolates sampled at healthcare
facilities in Eastern Saxony, including a university hospital, a
long-term rehabilitation facility and four county hospitals.
Isolates were included from routine diagnostic samples, as
well as from outbreak investigations, obtained between 2000
and 2007. Eighty representative MRSA isolates were selected
from among a collection of c. 300 isolates characterised by
a microarray described previously [10–13]. Additional
sequenced strains (see below) and representatives of epidemic
strains from other sources were also tested in order to obtain
hybridisation profiles for comparison by genotype pattern
matching (pattern matching algorithm in the partisan array-
LIMS software; CLONDIAG GmbH, Jena, Germany).
Preparation of genomic DNA
The protocol for DNA preparation has been described previ-
ously [11]. In brief, S. aureus isolates were cultured on Colum-
bia blood agar. Two inoculation loops of colony material were
suspended in a lysis buffer containing lysostaphin, lysozyme,
ribonuclease A, Tris-HCl, EDTA and Triton X-100. After
incubation, proteinase K and buffer AL (both from the DNeasy
kit; QIAgen, Hilden, Germany) were added. Finally, the sample
was processed using the EZ1 device (Qiagen).
Microarray-based genotyping
Diagnostic DNA microarrays, based on the ArrayTube plat-
form (CLONDIAG), were used as described previously
[10,11,16,17]. The arrays carried covalently immobilised probes
for the identification of agr (accessory gene regulator) groups
[18,19], antibiotic resistance determinants and exotoxins of
S. aureus, as well as probes for set ⁄ ssl genes (staphylococcal
superantigen-like or exotoxin-like genes) [20–22] and species
controls. Markers for capsule identification and SCCmec typing
(see below), and for the detection of allelic variants of
MSCRAMM genes, were also included. A complete list of
primers and probes is available upon request from the
corresponding author. Array evaluation was performed using
sequenced S. aureus strains Sanger MSSA476 (an ST1 methi-
cillin-susceptible S. aureus strain), MW2 (ST1-MRSA IV),
N315, Mu50 (both ST5-MRSA II), NCTC 8325 (ST8 MSSA),
COL (CC8 ⁄ ST250-MRSA I), USA300 (ST8-MRSA IV), and
Sanger MRSA252 (ST30-MRSA II). Sequenced strain RF122
was not available, but related veterinary isolates were also
used. Published sequences were used to predict hybridisation
patterns for these strains, which were then compared to the
actual hybridisation data. Additional evaluation procedures
for a subset of clinically important probes (toxins, resistance
genes) have been described previously [17].
For amplification and labelling, a linear and thermally
synchronised primer elongation reaction was performed using
a standard thermocycler. This allowed all targets to be
amplified and labelled simultaneously, using one specific
primer for each target. The labelling reaction comprised a
mixture of primers (0.135 lM each), dNTPs, biotin-16-dUTP,
Therminator polymerase [17] and 1–2 lg of target DNA.
Amplification was performed as described previously [17].
Compared with earlier protocols, the hybridisation proce-
dures were modified. Before hybridisation, the ArrayTube was
washed with 500 lL of double-distilled water and 500 lL of
Hybridisation Buffer 1 (CLONDIAG), each for 5 min at room
temperature while agitating at 550 rpm on a thermomixing
device. The labelled sample was diluted in Hybridisation
Buffer 1 to a final volume of 100 lL, denatured (2 min at 95C),
chilled on ice for 1 min, briefly centrifuged, and then trans-
ferred into the ArrayTube. The sample was then incubated for
60 min at 50C (550 rpm), and then removed completely from
the tube. The array was washed three times (each for 5 min at
room temperature, 550 rpm), first with 500 lL of 2 · SSC
(2 · SSC is 0.3 M NaCl, 0.3 M trisodium citrate, pH 7.0)
containing Triton X-100 0.01% v ⁄v, then with 500 lL of
2 · SSC, and finally with 500 lL of 0.2 · SSC. This was
followed by the addition of 100 lL of a blocking reagent
(CLONDIAG) 2% w ⁄v solution, freshly dissolved in 6 · SSPE
(1 · SSPE is 150 mM NaCl, 10 mM sodium phosphate, 1 mM
EDTA) containing Triton X-100 0.1% v ⁄v, and incubation of
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the ArrayTube for 15 min at 30C, 550 rpm. Horseradish
peroxidase–streptavidin conjugate (Pierce, Rockford, IL, USA)
was pre-diluted to 1:50 in 1 · phosphate-buffered saline from
a stock solution, and then diluted 1:100 in 6 · SSPE containing
Triton X-100 0.1% v ⁄v to give a final concentration of
100 pg ⁄ lL. The blocking solution was removed and 100 lL
of the diluted conjugate was added to the ArrayTube, followed
by incubation (15 min, 30C, 550 rpm) and another three
washing steps as described above. The ArrayTube was then
placed in an ATR01 reading device (CLONDIAG) and 100 lL
of Seramun Green-precipitating horseradish peroxidase sub-
strate (Seramun, Heidesee, Germany) was added. After stain-
ing for 5 min, the resulting array image was recorded and
analysed.
Data interpretation
The local precipitation of dye results in clearly visible spots
that can be read by superimposition of a coordinate grid over
an enlarged digital picture of the processed array; the presence
of spots is regarded as a positive hybridisation event. In order
to facilitate computerised data interpretation, an algorithm
was developed, based on measurement of light transmission
through the spots with respect to their surroundings. Break-
points for the definition of positive or negative signals were
defined for each individual experiment, based on the actual
measurements for positive control markers. Details of this
procedure have been described previously [11].
agr and spa typing
agr groups were determined by microarray hybridisation. spa
typing was performed according to a method described
previously [23], using the SPATypemapper program
for interpretation (http://www.clondiag.com/technologies/
download.php?file=spa).
SCCmec typing
SCCmec typing was performed by detection of the recom-
binase (ccrA, ccrB, ccrC) and accessory genes that form part
of the SCCmec cassettes. The structure and gene content of
these cassettes have been described previously [1,5,24].
However, in contrast to published protocols, detection was
achieved not by PCR, but by hybridisation to a set of probes
on a DNA array. In general, probes for mecA and ugpQ
(glycerophosphoryldiesterase) were used to detect SCCmec
resistance islands of any type. SCCmecI was identified by
hybridisation results positive for crrA1, crrB1, truncated
mecR (DmecR), pls (plasmin-sensitive surface protein) and the
dcs region. Identification of SCCmecII was based on the
detection of crrA2, crrB2, mecI, non-truncated mecR, the kdp
operon (kdpA–kdpE), xylR and the dcs region. The aadD and
ermA resistance genes were not regarded as prerequisite for
SCCmecII, because of their variable presence. For SCCmecIII
identification, probes recognising crrA3, crrB3, mecI, xylR and
non-truncated mecR were utilised. The variable presence of
the tetK resistance gene meant that it was not regarded as
evidence for the presence of a type III cassette. Similarly,
detection of the mercury resistance operon (merA, merB,
merR, merT) was not regarded as positive evidence for a
type III cassette, as this operon was also found in isolates
carrying other SCCmec types. ccrA probes designed for
identification of an atypical SCCmec cassette, originally
described as type III, from strain 85 ⁄ 2082 (GenBank
AB037671) cross-reacted with both SCCmecIII and SCCmecV.
An isolate was assigned to SCCmecIV if crrA2, crrB2,
truncated mecR and dcs were present, but (in contrast to
SCCmecII) the kdp genes were absent and occurrence of xylR
was variable. Identification of SCCmecV was based on
positive hybridisation reactions with probes for ccrAA
(GenBank AM292304.1) and ccrC (GenBank AB037671),
although the latter also cross-reacted with ccrB3. SCCmecV
isolates were not required to display reactivity with the
probe for truncated mecR, as published sequence data
(GenBank AB121219.1, DQ171730.1) indicate more extensive
deletions in SCCmecV than in SCCmecI and SCCmecIV, and
also a loss of the binding sites of primer and probe for
truncated mecR. SCCmecVI was identified on the basis of
detection of ccrA4 and ccrB4.
RESULTS
All the isolates tested could be assigned unam-
biguously to clonal groups by analysing hybridi-
sation patterns once a reference strain that had
been MLST ⁄ spa-typed for each clonal group had
been defined. SCCmec typing by hybridisation
yielded results in accord with data published
previously for the respective strains. A simplified
summary of the hybridisation results for discern-
ible epidemic strains and reference strains is
provided in Figs 1–4. Full hybridisation results
for all isolates tested are available upon request
from the corresponding author. Brief summaries
of the characteristics of clinical isolates according
to their clonal group are given below.
Clonal group 1
USA400, a PVL-positive caMRSA strain from this
clonal group, has not yet been found in Eastern
Saxony, but closely related PVL-negative ST1-
MRSA IV isolates have been detected in three
cases (a specimen from paediatric surgery and
two specimens from the skin lesions of patients in
a dermatological department). In contrast to the
sequenced USA400 strain MW2, these isolates
lacked sec, sel and PVL, but their hybridisation
patterns were otherwise virtually identical to that
of MW2. The isolates belonged to capsule type 8
and carried genes encoding enterotoxin A (sea),
staphylokinase (sak) and staphylococcal comple-
ment inhibitor (scn), and thus belonged to IEC
type D [14]. Carriage of ssl ⁄ set genes and of genes
encoding MSCRAMMs was homogeneous and
identical to that of MW2.
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Clonal group 5
Clonal group 5 was represented by two abundant
EMRSA strains (South German and Rhine–
Hesse), and by two sporadic strains. All isolates
belonged to capsule type 5 and were uniform in
terms of carriage of ssl ⁄ set genes and genes
encoding MSCRAMMs. Allelic variants of these
Fig. 1. Hybridisation results for antibiotic resistance genes and genes from SCCmec cassettes. Sequenced reference strains
are underlined. Black squares, always positive; grey squares, variable.
Fig. 2. Hybridisation results for genes encoding virulence-associated factors, including superantigenic toxins, leukocidins,
haemolysins, proteases and other exotoxins or enzymes. Sequenced reference strains are underlined. Black squares, always
positive; grey squares, variable or ambiguous.
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genes were generally identical to those of the
sequenced strains Mu50 and N315. Clonal
group 5 MRSA harboured the enterotoxin gene
cluster egc (comprising enterotoxin genes seg, sei,
sem, sen, seo and seu ⁄ y), but the isolates differed
with respect to their carriage of additional toxin
genes (see below) and resistance-associated genes,
including SCCmec types. All isolates carried fosB
Fig. 3. Hybridisation results for genes encoding microbial surface components recognising adhesive matrix molecules or
genes related to biofilm formation and capsule type. Black squares, always positive; grey squares, variable or ambiguous.
Fig. 4. Hybridisation results for agr and ssl ⁄ set (staphylococcal superantigen-like or exotoxin-like) genes. Black squares,
always positive; grey squares, variable or ambiguous.
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(encoding a metallothiol transferase conferring
fosfomycin resistance).
An SCCmecI strain from this clonal group is
known as the South German Epidemic Strain
(ST228, spa t001, t041 or t811). This is one of the
four most common MRSA strains in Eastern
Saxony. It is quite resistant, with isolates carrying
the aacA–aphD, aphA, sat and qacA (encoding a
multidrug efflux protein) genes. In contrast to
other clonal group 5 strains, the gene for fibro-
nectin-binding protein B (fnbB) was not detectable
in this strain. The haemolysin-b (hlb) gene was
always disrupted, and all isolates belonged to IEC
type D [14]. Altogether, four variants of the South
German Epidemic Strain were discernible, based
on the variable presence of the mercury resistance
operon, ermA, mupR, dfrA, clfA (encoding clump-
ing factor A) and bbp (bone ⁄ sialoprotein binding
protein). A distinctive fifth variant of this strain
(also spa t001) had a truncated egc locus, being
positive only for the enterotoxin gene seo. It also
lacked the lukD ⁄E leukocidin genes. In addition to
the isolate described here, three other isolates
were found between 2005 and 2007, all of which
were linked to a single ward in a rehabilitation
facility.
A related strain is the Rhine–Hesse Epidemic
Strain, also known as EMRSA-3 or New-York ⁄
Japan Clone (spa t003 or t627). Locally, this was
one of the four most abundant strains. Isolates
carried an SCCmecII element, which was in accord
with the presence of ermA and, in most isolates, of
aadD. The Rhine–Hesse EMRSA strain is related
closely to the sequenced strain N315. Most
isolates carried a distinctive allelic variant of sea
(sea-N315, also known as sep), described originally
in N315 [25]. Enterotoxin carriage (sea-N315,
sed + sej + ser) and the presence or absence of
resistance genes (blaZ, aadD, aacA–aphD, aphA3,
sat and tetM) allowed eight variants to be distin-
guished. Identification of these variants can
be helpful for epidemiological purposes. For
instance, seven of nine isolates that were
sea-N315–, sed ⁄ j ⁄ r+, blaZ+ were epidemiologically
linked, being sampled from a single hospital
during 2003–2004. As the sak, scn and chp (encod-
ing chemotaxis inhibitory protein) genes were
present, Rhine–Hesse EMRSA isolates belonged
either to IEC type B or IEC type F, depending on
the carriage of sea-N315.
A related strain (spa t002, t067) carried an
SCCmecIV element, corresponding to the interna-
tionally known ‘Paediatric clone’. This clone was
rare, with only four isolates identified to date. It
differed from the Rhine–Hesse EMRSA strain in
lacking ermA, which is in accord with the pres-
ence of an SCCmecIV element, but three isolates
were positive for aadD. Three isolates harboured
sea-N315, sed, sej and ser, and two were positive
for seb. The isolates belonged to IEC types B or F
[14]. PVL-positive variants of this strain, as
reported in other countries, have not been found
in Eastern Saxony to date.
A unique isolate belonging to clonal group 5
(t067) was obtained from a patient with severe
pneumococcal pneumonia who was repatriated
from the Canary Islands. This isolate yielded
positive hybridisation signals with the probes for
SCCmecIV, SCCmecVI, ermA, ermC, msrA, mpbBM
(encoding macrolide 2¢-phosphotransferase),
aadD, aphA3 and sat. It belonged to IEC type E,
carrying sak and scn.
Clonal group 8
MRSA strains from clonal group 8 generally gave
hybridisation patterns related to those of the
sequenced strains COL, USA300 and NCTC
8325. Carriage of the ssl ⁄ set genes and the genes
encoding MSCRAMMs was rather homogeneous,
and resembled that of these sequenced strains.
With the exception of ST239 (see below), isolates
belonged to capsule type 5 and lacked cna (encod-
ing collagen-binding adhesin). Carriage of genes
encoding resistance properties and exotoxins, as
well as of IEC genes, was variable, thereby
allowing several strains to be distinguished.
One strain from this group, known as Ancestral
or Ancient MRSA, is a CC8 ⁄ ST250-MRSA I
strain, represented by the sequenced strain COL.
No clinical isolates of the Ancient MRSA were
found.
Another strain in this clonal group is PVL-
positive ST8-MRSA IV, also known as USA300.
Two cases of community-acquired infections with
this strain have been identified to date in Eastern
Saxony. Two additional cases were referred from
a neighbouring county in the Federal State of
Brandenburg. All four isolates carried msrA,
mpbBM, aphA3 and sat, but lacked ermC, tetK
and mupR, indicating a plasmid content different
to that of the sequenced USA300 isolate
(NC_007790, NC_007791, NC_007792,
NC_007793). The hybridisation results for other
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genes were in accord with the published genome,
including the presence of PVL genes, the ACME
operon, and enterotoxin genes sek and seq.
Two cases of infection were noted with a
related strain that was also ST8, spa t008 and
SCCmecIV. In contrast to USA300, this strain did
not carry the PVL, ACME or sek or seq genes, but
harboured sea, sed, sej and ser, as well as aadD.
This strain belonged to IEC type D [14]. A follow-
up isolate from one of the two patients was found
to have acquired far1 (fusidic acid resistance) and
tetK.
Another, locally relevant, strain was the Han-
nover Epidemic Strain, ST8-MRSA IV, spa t009.
This strain was apparently introduced to Saxony
shortly after German reunification, and was com-
mon during the 1990s (L. Jatzwauk, personal
communication), but no isolate has been identi-
fied since 2001. Isolates of this strain carried ermA,
aacA–aphD, aphA3, sat and tetM, and were resis-
tant to co-trimoxazole, but without harbouring
dfrA. This strain belonged to IEC type D [14]. In
addition to sea, it harboured the enterotoxin genes
seb, sek and seq. In contrast to other ST8-MRSA
strains, but in accord with, e.g., NCTC 8325, it
lacked bbp. Two variants that differed in their
carriage of genes associated with SCCmec ele-
ments were distinguishable. One variant carried
the mecA, DmecR, ugpQ, dcs, ccrA2 and ccrB2
genes, and also generated positive signals with
the probes for ccrAA-85 ⁄ 2082 and ccrC-85 ⁄ 2082.
The other variant was positive for mecA, DmecR,
ugpQ and dcs, and also carried the mercury
resistance operon.
Another strain belonged to ST8, spa t064 and
SCCmecIV, and was possibly related to USA500
(http://spa.ridom.de/spatypes.shtml [26]). Three
imported cases, from Ethiopia (probably commu-
nity-acquired), Zimbabwe (hospital-acquired) and
Mozambique (community-acquired), respectively,
were found. This strain harboured seb, sek and seq,
and was resistant to erythromycin, clindamycin
(ermA) and rifampicin. The isolates varied in their
carriage of aacA–aphD, tetM, sea, sak and scn.
One MRSA isolate, belonging to clonal group 8
(t008), carried SCCmecV and was positive for
ermC and tetK, but, as with NCTC 8325, did not
carry enterotoxin genes. This isolate belonged to
IEC type D [14].
ST239-MRSA III (Vienna, Hungarian or
Brazilian clones) was found to be involved in a
nosocomial outbreak following the repatriation of
a trauma patient from Rhodes, Greece. This strain
harboured the ermC, aacA–aphD, aphA3, sat and
tetM genes. It carried only the enterotoxin A gene
(sea), although ST239-MRSA III may also harbour
sek and seq. IEC gene carriage was in accord with
IEC type D [14]. ST239 is unique, as it can be
regarded as the result of a large-scale recombina-
tion event involving the parental strains of clonal
groups 8 and 30 [27]. Indeed, alleles of ssl ⁄ set and
most MSCRAMM genes were typical for ST8
strains, but the arcC allele (carbamate kinase, used
in multilocus sequence typing (MLST) [28]),
capsule type 8 (instead of type 5), spa type
(t037), the allelic variant of the aureolysin (aur)
gene and the presence of cna indicated the
insertion of a chromosomal fragment from clonal
group 30.
Clonal group 22
A clonal group 22 strain, ST22-MRSA IV, also
known as the Barnim Epidemic Strain [29] or
EMRSA-15, was one of the four most abundant
MRSA strains in Eastern Saxony. In terms of
hybridisation profiles, clonal group 22 was not
related to clonal groups 1, 5 and 8, but shared
some features with clonal group 45. The ssl ⁄ set
gene patterns were atypical and showed cross-
reactivity among probes for different allelic
variants of a given gene. Probes for the hlgA,
lukF–hlg and lukS–hlg genes regularly gave weak
signals. Both of these observations could indi-
cate the presence of, as yet, unsequenced alleles.
For lukS–hlg, a specific probe was constructed,
based on an ST45 sequence (GenBank
EF672356). This probe yielded positive results
for ST22 and ST45.
All clonal group 22 isolates harboured the egc
locus, but protease genes splA, splB and splE were
not detected. The capsule type was 5, and the vast
majority of isolates belonged to IEC type B. Some
isolates had non-truncated hlb and lacked the IEC
genes. Depending on the carriage of enterotoxin
genes (sec and sel), haemolysin b-converting
phages, ermC and the MSCRAMM genes (fnbB,
bbp), a total of eight variants could be distin-
guished.
ST22-MRSA IV was found among hospital
isolates from apparently community-acquired
infections. In particular, it was associated with
diabetic foot ulcers, although this might, in part,
be attributable to an outbreak of one variant
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(sec ⁄ l), ermC), IEC+) in a ward and outpatient
department specialising in the care of such
patients. The PVL-positive ST22-MRSA IV out-
break strain from Bavaria [9] has not yet been
detected in Eastern Saxony.
Clonal group 30
Clonal group 30 MRSA strains are ST36-MRSA
II, or EMRSA-16 (represented by sequenced
strain MRSA 252), and the PVL-positive ST30-
MRSA IV strain, also known as WSPP or
South-West Pacific clone. The former was not
detected in isolates from Eastern Saxony, while
the latter was detected in two cases of commu-
nity-acquired ‘insect-bite-like’ infections. One of
these isolates harboured aacA–aphD and tetK.
Toxin and set ⁄ ssl gene carriage have been
described previously [10]. Carriage of allelic
variants of MSCRAMM genes was similar to
that of MRSA252; differences from MRSA252
included the presence of fnbB and sdrD.
Clonal group 45
Clonal group 45 strains resembled those of
clonal group 22 in terms of atypical ssl ⁄ set and
luk ⁄ hlgA gene patterns (see above). ST45 isolates
also carried the egc cluster, but in contrast to
ST22, belonged to capsule type 8. These isolates
had a unique allele of the gene for the bone-
binding protein (bbp). The sasG (biofilm produc-
tion ⁄protein G) gene was conspicuously absent
from this clonal group, as in clonal groups 30
and 398.
ST45-MRSA IV, also known as the Berlin
Epidemic Strain (spa t004 or t040), was one of
the most abundant local MRSA strains. Ten
variants of this strain could be distinguished
using the microarray. The variations observed
affected resistance genes aacA–aphD, aadD, ermC,
dfrA, aphA3, sat and tetK, as well as a common
deletion of an enterotoxin gene (seg) from the egc
cluster. All except one of the isolates (which
lacked IEC genes) belonged to IEC type B. A
related strain, or an eleventh variant, was an
ST45-MRSA IV strain, which differed in the
presence of additional enterotoxin genes (sec, sel)
and the absence of aphA3 plus sat. This strain was
detected only once, but has also been detected in
Sweden and The Netherlands (A. Matussek and F.
H. J. Schuren, personal communication).
In 2007, a single isolate of an ST45-MRSA V
strain was detected which was otherwise very
similar to the Berlin Epidemic Strain.
Clonal group 59
A single isolate belonging to clonal group 59 was
obtained from a community-acquired infection.
The isolate was a PVL-positive SCCmecV strain,
similar to isolates characterised previously from
Australia and the UK [10], and was resistant to
erythromycin, clindamycin and quinupristin–dal-
fopristin, but was susceptible to linezolid. How-
ever, the isolate yielded negative hybridisation
results for all macrolide and streptogramin resis-
tance genes tested, as well as for cfr (23S RNA
methylase). The isolate carried chp and scn, and
belonged to IEC type C [14].
Clonal group 80
ST80-MRSA IV, or European Clone (spa t044 or
t131), was the most prevalent PVL-positive, com-
munity-acquired MRSA strain in Eastern Saxony,
with eight isolates being obtained from Dresden
or nearby counties (Freiberg, Pirna and
Hoyerswerda) in the period until October 2007.
Three cases were considered to be hospital-asso-
ciated; two of these have been described previ-
ously [10], while the third was a case of
septicaemia in a patient suffering from diabetic
gangrene. Details of the carriage of toxin and
resistance genes have been described previously
[10]. In brief, this strain carries exfoliative toxin D
(etD) and an epidermal cell differentiation inhib-
itor (edinB). Most isolates also harboured a plas-
mid encoding a b-lactamase, fusidic acid (far1)
and tetracycline (tetK) resistance. The cna gene
was absent among the MSCRAMM genes, but the
IEC genes chp and sak were present, correspond-
ing to type E [14].
Clonal group 398
ST398-MRSA V is a recently described strain,
occurring in humans and a variety of domestic
animals [30], that has been involved in outbreaks
of infection affecting pig farmers [31,32]. The
present study identified a single isolate of a
spa t011 MRSA strain from a urinary tract infec-
tion in a child. This isolate carried an SCCmecV
element and the tetK and tetM genes. It differed
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from previously described [12,30] veterinary
ST398-MRSA V isolates by the absence of aacA–
aphD, ermA and ermC. The capsule type was 5,
and the cna gene was present. Enterotoxin genes
(except for a ubiquitous homologue), IEC and
protease genes splA, splB and splE, as well as sasG,
were not detected.
DISCUSSION
Diagnostic DNA microarrays allow the rapid
identification of isolates and a comprehensive
assessment of virulence properties and antimi-
crobial resistance genes under routine conditions.
Complete hybridisation patterns allow isolates to
be assigned to clonal groups [11]. Combined with
a novel scheme for hybridisation-based SCCmec
typing, this facilitates identification and charac-
terisation of MRSA isolates and their assignment
to epidemic strains. By analysing isolates from
routine diagnostic laboratories and outbreak
investigations, it was possible to obtain insights
into the local occurrence of MRSA strains and
SCCmec elements, as well as clinically relevant
virulence factors, e.g., superantigenic toxins or
PVL.
The vast majority of MRSA infections or colo-
nisations in Eastern Saxony could be attributed to
four strains i.e., South German EMRSA (CC5 ⁄
ST228-MRSA I), Rhine–Hesse EMRSA (ST5-
MRSA II), Barnim EMRSA (ST22-MRSA IV)
and Berlin EMRSA (ST45-MRSA IV). Other
MRSA strains were rare in comparison, and were
only detected in isolated cases. The predominant
SCCmec types were I, II and IV. SCCmecI elements
are still common, being present in the South
German EMRSA strain. The Ancestral MRSA
(CC8 ⁄ ST250-MRSA I) strain was not found.
SCCmecII was restricted to one of the abundant
strains (Rhine–Hesse EMRSA). Variation in this
element was noted, as some isolates lacked the
tobramycin resistance gene aadD. As this gene is
carried by the plasmid pUB110, these strains can
be classified as either pUB110-deficient vari-
ant IID (2A.3.4) or pUB110-deficient variant IIb
(2A.2) [33]. A second internationally important
SCCmecII strain, ST36-MRSA II (EMRSA-16), was
not detected, and SCCmecIII (ST239-MRSA III)
was detected only in a single nosocomial outbreak
following its importation from southern Europe.
This latter strain is remarkable, as it appears to be
some kind of hybrid derived from clonal group 8
and clonal group 30 parental strains. The array
data confirmed the data obtained by MLST [27],
and allowed the parentage of additional genes to
be traced. Approximately half of the MRSA
strains detected carried SCCmecIV elements, and
belonged mostly to the Barnim and Berlin EMRSA
strains. Another hospital-acquired MRSA strain
carrying SCCmecIV was the Hannover EMRSA
(ST8-MRSA IV), which appears to have become
less common since the 1990s [34]. SCCmecV and
SCCmecVI elements are still rare.
While some of the strains detected are also
known to be abundant in other European coun-
tries (e.g., Rhine–Hesse EMRSA or EMRSA-3, and
the Barnim Epidemic strain or EMRSA-15), some
important strains found in other countries were
completely absent (e.g., EMRSA-16). Data from
the German national reference centre show an
overall increase in MRSA prevalence, and also a
shift in the relative frequencies of different strains
during the 1990s, with the North German and
Hannover EMRSA strains disappearing, and the
Barnim, as well as the Rhine–Hesse EMRSA
strains, showing a massive spread [29,34]. A
possible explanation is that the dissemination of
EMRSA strains into a low-prevalence region (e.g.,
Saxony during the 1990s) was achieved easily, but
that it was mainly a matter of chance which
strains actually spread. Thus, the absence of
EMRSA-16 was not the result of reduced fitness
in comparison with the regionally abundant
strains, but rather a chance failure to import this
strain to Saxony during the 1990s. When the
founder strains reached a certain prevalence,
competition among them might have resulted in
the elimination of some strains, perhaps because
they replicated more slowly, were less infectious,
or were more susceptible to environmental con-
ditions. It would be interesting to determine the
reasons that led to the decline in importance of
the North German and Hannover EMRSA strains.
The use of antibiotics was probably not respon-
sible, as these strains harbour more resistance
genes than the strains that have supplanted them.
Between 2000 and 2007, no new strains were
observed to gain ground, and although several
importations of strains (including an ST239-
MRSA III outbreak) were observed, none became
permanently established. It can be assumed that
newly imported strains might face difficulties in
becoming established in a setting with a high
prevalence of previously well-established strains.
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Successful establishment in such an environment
would require either a major selective advantage
resulting from novel pathobiochemical proper-
ties (e.g., those associated with USA300 in the
USA) or importation on a massive scale. Simi-
larly, a significant influx of community-acquired
PVL-positive MRSA strains into the hospital
environment was not observed, although spo-
radic infections with PVL-positive ST80-MRSA IV
were recorded in diabetic or long-term rehabili-
tation patients, but close surveillance of this
strain, as well as of other PVL-positive strains, is
warranted because of their virulence and their
known epidemic potential [9,35,36]. PVL-positive
MRSA strains are still rare, although diversifica-
tion can already be observed, with the recognition
of an increasing number of different strains (ST80-
MRSA IV in 2004, USA300 in 2005, ST30-MRSA
IV in 2006, and ST59-MRSA V in 2007). Other
possibly emerging strains might include ST398-
MRSA V, which has been involved in outbreaks
affecting domestic animals and pig farmers in The
Netherlands [31,32], clonal group 5 strains carry-
ing SCCmecIV elements (Paediatric clone) and
ST45-MRSA V.
The DNA microarray allowed detection of sub-
strains or variants, especially within the more
common strains, which often differ in the carriage
of genes encoding leukocidins, enterotoxins and
accessory resistance determinants (e.g., ermC in
the Barnim EMRSA strain). Such variations in
gene content were observed in several major
strains revealed in the present study (Hannover,
Barnim, Berlin, South German, Paediatric and
Rhine–Hesse EMRSA strains, as well as ST80-
MRSA IV). The fact that no variations have been
observed to date in some other strains (e.g., ST1-
MRSA IV) might be attributed to the small
sample size and ⁄ or the recent proliferation of
these strains, rather than their genuine absence.
The clinical significance of the loss, or acquisition,
of exotoxin genes is not yet clear, but these genes
can be useful for subtyping. In the same way, the
presence and identity of haemolysin b-converting
phages can be used to distinguish variants within
a strain. Some variations were also noted with
respect to the presence of MSCRAMM genes.
However, the variability of these genes affected
mainly the number and sequence of repeating
units, which are not targeted by the probes on the
array. The probes were designed to recognise
conserved, non-repeat regions in order to detect
the presence or absence, rather than variation, of
these genes. Occasional deletions of the
MSCRAMM genes could affect the ability to
adhere to implants or intravenous lines, which
is of particular relevance for hospital-acquired
strains. All these variations in gene content can be
used for subtyping, and thus for tracking the
epidemiology of strains involved in outbreaks.
For instance, all isolates of a characteristic dele-
tion mutant of the South German EMRSA strain
(see above) were linked to a single ward. Such
discrimination at a level below spa types can be
very helpful for epidemiological purposes, espe-
cially in settings in which most MRSA cases can
be attributed to a small number of abundant
epidemic strains.
The DNA microarray used for the present
study facilitated a comprehensive genomic pro-
filing of S. aureus isolates. The laboratory effort is
comparable in time and cost to real-time PCR
assays for single genomic loci. Thus, the array
provides a valuable alternative approach to other
typing techniques, being less time-consuming and
adding discriminatory power to outbreak inves-
tigations. A large number of loci can be analysed
within a single experiment, combining the detec-
tion of clinically relevant virulence- or resistance-
associated genes and the typing of a given isolate.
Additional probes used in the present study
allowed identification of the SCCmec type, the
content of hlb-converting phages and the capsule
type. The overall hybridisation patterns generated
were found to correlate with the clonal complexes
defined by MLST. In contrast, probes for exotoxin
and antibiotic resistance determinants target
genes located on highly mobile genetic elements.
Their variability, even within a given strain,
might allow the subtyping of epidemic strains to
the level of hospital- or ward-specific variants. An
expansion of the database covering these varia-
tions might be of great value in epidemiological
studies of transmission events and links among
individual cases.
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